Press release
Segmentation, Major Trends, and Competitive Overview of the Uveal Neoplasms Market
Uveal Neoplasms Market
Anticipated Growth and Market Size of the Uveal Neoplasms Market by 2030
The global uveal neoplasms market is projected to reach $1.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.6%. This steady increase is driven by broader adoption of precision medicine in ophthalmology, heightened funding for ocular oncology research, and the expanding use of immunotherapy treatments. Additionally, the rising demand for minimally invasive eye therapies and advancements in imaging diagnostics are contributing to the market's upward trajectory. Throughout the forecast period, notable trends include greater implementation of targeted and immunotherapy treatments, increased use of sophisticated ocular imaging techniques, a stronger emphasis on early tumor detection, and the development of personalized treatment plans supported by multidisciplinary eye care.
Download a free report of the uveal neoplasms market report:
https://www.thebusinessresearchcompany.com/report/uveal-neoplasms-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Corporations Driving the Uveal Neoplasms Market
Several prominent companies dominate the uveal neoplasms sector, including Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., IDEAYA Biosciences Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Verastem Oncology Inc., Iovance Biotherapeutics Inc., Immunocore Holdings PLC, Aura Biosciences, Foghorn Therapeutics Inc., Syncona Limited, iOnctura SA, Linnaeus Therapeutics, Inc., Delcath Systems Inc., and Bellicum Pharmaceuticals Inc.
In a significant development in August 2023, US-based oncology firm TriSalus Life Sciences merged with MedTech Acquisition Corporation, a special purpose acquisition company focusing on medical technology. This strategic alliance aims to bolster TriSalus' platform for treating liver and pancreatic cancers, including uveal melanoma with liver metastases. The merger is expected to accelerate technology advancements, drive revenue growth, and secure necessary funding for key projects through mid-2024.
View the full uveal neoplasms market report:
https://www.thebusinessresearchcompany.com/report/uveal-neoplasms-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Influencing the Uveal Neoplasms Market
Industry players are increasingly adopting advanced liver-directed therapies such as percutaneous hepatic perfusion (PHP) to improve local tumor control while minimizing systemic side effects. PHP is a minimally invasive procedure that isolates the liver's blood supply, delivering high doses of chemotherapy directly into the hepatic artery and filtering blood exiting the liver. This targeted approach concentrates treatment on tumors and limits exposure to the rest of the body.
For example, in August 2023, Delcath Systems Inc., a US-based interventional oncology company, received FDA approval for the HEPZATO KIT. This PHP-based therapy is designed for patients with metastatic uveal melanoma featuring unresectable liver-dominant metastases. HEPZATO KIT administers a targeted melphalan infusion combined with extracorporeal filtration of hepatic blood, with treatment cycles generally repeated every 6 to 8 weeks as clinically appropriate. Clinical data has demonstrated notable benefits, including significant tumor responses and disease control in eligible patients, while reducing systemic drug exposure.
Comprehensive Segmentation of the Uveal Neoplasms Market
The uveal neoplasms market is analyzed across several key segments:
1) Treatment Type: Drugs and Therapy
2) Route of Administration: Oral, Injectable, and Other Routes
3) Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies
Further subcategories include:
- Drugs: Chemotherapeutic Agents, Targeted Therapy Drugs, Immunotherapy Drugs
- Therapy: Radiation Therapy, Laser Therapy, Photodynamic Therapy
This detailed segmentation provides a nuanced understanding of how various treatment options and distribution methods contribute to the overall market structure.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Segmentation, Major Trends, and Competitive Overview of the Uveal Neoplasms Market here
News-ID: 4491354 • Views: …
More Releases from The Business Research Company
In-Depth Review of Segments, Industry Developments, and Key Players in the Virtu …
The virtual intensive care unit (ICU) market is gaining significant traction as healare systems seek more efficient and scalable critical care solutions. Driven by digital innovation and evolving care models, this sector is set to transform how intensive care services are delivered, making advanced monitoring and expert care more accessible across various regions.
Projected Growth Path for the Virtual Intensive Care Unit Market
The virtual ICU market is anticipated to…
Leading Companies Fueling Growth and Innovation in the Virtual and Remote Labora …
The virtual and remote laboratories market is on the brink of significant expansion, driven by rapid technological advancements and growing demands for flexible learning solutions. With increasing digitalization in education and research, this sector is poised to transform how experiments and practical training are conducted worldwide. Let's explore the market's projected growth, key players, emerging trends, and the various segments defining this evolving industry.
Projected Market Size Growth for Virtual and…
Key Factors and Emerging Trends Shaping the Viral Vector Service Market Landscap …
The viral vector service market is set to experience remarkable expansion over the coming years, driven by rapid advancements in gene therapy and biopharmaceutical manufacturing. As demand for specialized viral vectors grows alongside regulatory expectations, the industry is poised to deliver innovative solutions that support the evolving needs of gene-based medicines and research.
Projected Growth and Market Size of the Viral Vector Service Market
The viral vector service market is…
In-Depth Review of Segments, Industry Developments, and Key Competitors in the V …
The viral hepatitis market is on a steady upward trajectory, driven by growing global efforts to combat the disease and advancements in medical technology. Increasing investments in innovative treatments and expanded diagnostic methods are setting the stage for consistent growth through 2030. Below is an overview of the market's projected size, key players, emerging trends, and segmentation details.
Projected Expansion and Market Value of the Viral Hepatitis Market
The viral…
More Releases for Uveal
Uveal Neoplasms Market Detailed Industry Report Analysis 2025-2034
Introduction
Uveal neoplasms, also referred to as uveal melanomas and related tumors, are rare malignancies that arise from the uveal tract of the eye, which includes the iris, ciliary body, and choroid. Among these, uveal melanoma is the most common primary intraocular malignancy in adults. Despite its rarity, it carries high morbidity and mortality risks, especially when it metastasizes to the liver.
Traditional management strategies - including surgery, radiotherapy, and enucleation -…
Metastatic Uveal Melanoma Therapeutics Market: An In-Depth Analysis
The Metastatic Uveal Melanoma Therapeutics market was valued at USD 1.23 billion in 2023 and is projected to reach approximately USD 3.00 billion by 2033, growing at an estimated CAGR of around 8.9% from 2024 to 2033.
Metastatic Uveal Melanoma Therapeutics Market Overview
The Metastatic Uveal Melanoma Therapeutics market is evolving rapidly with the emergence of novel targeted and immunotherapeutic treatments addressing this rare and aggressive cancer. Increasing research into tumor-specific pathways…
Global Uveal Melanoma Treatment Market Will Generate Record Revenue by 2028
This Uveal Melanoma Treatment market report is the product of thorough market study and comments on important factors that influence financial decision. Here, helpful insights on customer demands are provided in order to launch the best product or service on the market. COVID-19's detrimental effects on the world economy system are also captured in this way. As a result of the pandemic, some businesses experienced considerable financial losses. Several businesses…
Uveal Melanoma Therapeutics- Clinical Trials & Results | HARMONIC PHARMA, Immuno …
Uveal melanoma is the most common primary malignant tumour of intraocular malignancy, arises from melanocytes in the iris, and ciliary body.
Download the sample report @ https://www.pharmaproff.com/request-sample/1121
The most common symptoms of uveal carcinoma include blurred vision, photopsia, visual field loss, visible tumour, pain, and metamorphopsia. The management of uveal melanoma can be divided into globe-preserving therapy or enucleation. Globe-preserving therapies can broadly classified into radiation, surgical, and laser therapy.
Get…
Uveal Melanoma Global Market Research Report 2025
Uveal Melanoma Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/uveal-melanoma-market/80986
The report firstly introduced the Uveal Melanoma basics: definitions, classifications, applications and…
Uveal Melanoma Market By Analysis of Major Industry Segments 2024
Global Uveal Melanom Market: Overview
Uvea is present posterior to sclera and the cornea and has three parts namely, iris, ciliary body and choroid. Uveal melanoma is referred as the cancer of the parts of eye including the iris choroid and ciliray body. It is the condition in which the tumors arise from the melanocytes residing within the uva responsible for the color of the eye. Though is a rare…
